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Shear stress magnitude and directionality
modulate growth factor gene expression in
preconditioned vascular endothelial cells
Anthony G. Passerini, PhD,a Amy Milsted, PhD,b and Stanley E. Rittgers, PhD,a Akron, Ohio
Objective: The purpose of this study was to simultaneously monitor the transcriptional levels of 12 endothelial growth
factor genes in response to alterations in wall shear stress (WSS) under conditions relevant to the development of intimal
hyperplasia, a major cause of arterial bypass graft failure.
Methods: Human umbilical vein endothelial cells were preconditioned in vitro under steady flow (WSS, 15 dynes/cm2) for
24 hours before being subjected to WSS at 25 (  10), 15 (  0), 5 (  10), 2.5 (  12.5), and 0 (  15)
dynes/cm2 or low magnitude WSS reversal (2.5 dynes/cm2) for 6 hours. A focused complementary DNA array was
used to simultaneously measure messenger RNA expression levels for END1, endothelial nitric oxide synthase (NOS3),
platelet-derived growth factor A, platelet-derived growth factor B (PDGFB), acidic fibroblast growth factor, basic
fibroblast growth factor, transforming growth factor-, transforming growth factor-, vascular endothelial growth
factor, insulin-like growth factor-1, epidermal growth factor, and angiotensin converting enzyme.
Results: Preconditioning significantly (P < .05) increased the fold expression of NOS3 (4.1  1.4), basic fibroblast
growth factor (3.90  1.16), vascular endothelial growth factor (3.39  1.04), and insulin-like growth factor-1 (2.8 
0.7) but decreased END1 (0.47 0.05) and PDGFB (0.70 0.04) messenger RNA expression levels relative to no-flow
controls, an effect that was sustained on removal from flow for 6 hours. Notably, the ratio of END1/NOS3 expression
was diminished (0.11  0.03) relative to that of cells maintained in static culture. Although few differences in gene
expression from baseline (15 dynes/cm2) were measured in cells exposed to either constant ( 0) or step decreases (
10,12.5, or15 dynes/cm2) in WSS, marked changes were seen in the group exposed to a step increase in WSS ( 
10) or to WSS reversal. Low magnitude retrograde WSS evoked significant (P < .05) transcriptional changes in multiple
genes, including elevated END1 (4.1  0.5), platelet-derived growth factor A (1.5  0.2), PDGFB (2.3  0.3), and
transforming growth factor- (1.5  0.2) levels, but depressed NOS3 (0.60  0.17) levels, and a marked increase in
END1/NOS3 (6.7  1.6) when compared with equal magnitude antegrade WSS (2.5 dynes/cm2).
Conclusion: These results support the implementation of a preconditioning phase for in vitro WSS studies to establish a
physiologic baseline. Our findings complement previous macroscale findings and are consistent with a cellular mechanism
involving increased END1 and PDGFB levels, but decreased NOS3 levels, leading to intimal hyperplasia at regions of low
magnitude reversing WSS. (J Vasc Surg 2003;37:182-90.)
The response of endothelial cells (ECs) to biomechani-
cal stimuli is of importance in both normal vascular physi-
ology1-5 and numerous pathologies.6-8 Growth factors ex-
pressed by ECs in response to luminal wall shear stress
(WSS)9-15 may contribute to the pathology of intimal
hyperplasia (IH), a major cause of bypass graft failure,6,16
through their effects on the underlying myoblasts. The
extra-anatomic geometry of the end-to-side distal anasto-
mosis17,18 results in regions of low and reversing flow
(WSS) along the vessel floor19-21 where the ECs are essen-
tially intact. Clinical observations22 and results from in
vitro20,21 and in vivo6,18,19,23-25 studies have shown an
inverse relationship between WSS and IH and implicated
the possible importance of flow reversal.13,25
In vitro studies have identified numerous growth fac-
tors whose expression in ECs is modulated by WSS,9-15
both at the transcriptional level and at the protein level
(Table I). In general, factors that have opposing effects on
vascular smooth muscle cells are oppositely regulated by
shear stress, a finding consistent with the development of
IH at regions of low WSS. However, this evidence is often
contradictory and limited in scope by several experimental
factors, including the use of a static culture baseline.4,23
In this study, we used a focused complementary DNA
(cDNA) array to simultaneously measure the transcrip-
tional levels of multiple endothelial growth factor genes of
possible importance in IH over a broad range of clinically
relevant WSS. We also described the use of a precondition-
ing protocol to reset the baseline for EC gene expression
from static culture levels.
MATERIALS AND METHODS
Human umbilical vein ECs (HUVECs) were supplied
as frozen primaries that were pooled from several donors
(lot #P149, Clonetics Corp, San Diego, Calif). They were
cultured in endothelial growth medium (Clonetics Corp)
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supplemented with a penicillin (100 U/mL), streptomycin
(100 g/mL), and Fungizone (0.25 g/mL) mixture
(BioWhittaker, Walkersville, Md). Cells (passages 1
through 4) were seeded (5000/cm2) on 75-mm 50-mm
glass microscope slides (Corning, Inc, Corning, NY),
treated with 10 g/cm2 human fibronectin (Fisher Scien-
tific, Pittsburgh, Pa), and placed within custom-designed
polycarbonate culture chambers (16-cm2 culture area). At
cell confluency, the slides were transferred to parallel-plate
flow chambers (gap height, 0.250 mm; width, 32.0 mm;
length, 50.0 mm; entrance/exit regions, 3.0 mm each;
maximum Reynolds’ number, 48; at WSS, 25 dynes/cm2),
for which the fluid mechanics have been well de-
scribed.26,27 The chambers were placed within a recirculat-
ing flow loop consisting of four independent circuits in
parallel (50 mL media/circuit). Flow was driven by a
Masterflex L/S peristaltic pumping system (Cole-Parmer
Instrument Co, Vernon Hills, Ill).
The shear stress protocol applied to the HUVEC
monolayers is shown in Fig 1. Cells first were precondi-
tioned with steady flow at a normalized arterial shear stress1
of 15 dynes/cm2 for 24 hours. The flow then was adjusted
to apply shear stresses of 25, 15, 5, 2.5, 0, or 2.5 dynes/
cm2 (representing step changes in WSS of   10, 0,
10, 12.5, 15 dynes/cm2, or WSS reversal) for 6
hours. Absolute WSS levels were chosen to span the range
of values that were shown to be relevant to IH progression
in a previous canine study.25 The “negative” shear level was
brought about with flow in the direction opposite that
established by the preconditioning protocol. Sixteen slides
(representing four replicate runs at each of four passages
from the same cell line [HUVEC P149]) were pooled for
each shear stress level to yield a single RNA sample per shear
level. This pooling was performed to eliminate potential
variation from increased passage number while acquiring
sufficient RNA for subsequent analysis. Sheared monolay-
ers were rinsed with phosphate-buffered saline solution, the
cells were lysed, and messenger RNA (mRNA) was isolated
with the Poly(A)Pure mRNA Isolation Kit (Ambion Corp,
Austin, Tex). mRNA also was isolated from cells main-
tained in static culture at passages 1 to 4.
The following sequence-verified human IMAGE Con-
sortium cDNA clones28 were used in array preparation: 
actin, glyceraldehyde-3-phosphate dehydrogenase
(GAPD; American Type Culture Collection, Manassas,
Va), ribosomal protein S9, END1, endothelial nitric oxide
synthase (NOS3), platelet-derived growth factor B chain
(PDGFB), platelet-derived growth factor A chain
(PDGFA), basic fibroblast growth factor (FGF2), acidic
fibroblast growth factor (FGF1), transforming growth fac-
tor- (TGFA), transforming growth factor-1 (TGFB1),
vascular endothelial growth factor (VEGF), insulin-like
growth factor-1 (IGF1), and epidermal growth factor
(EGF; Research Genetics, Carlsbad, Calif). The clone for
endothelial angiotensin converting enzyme (ACE) was
provided by the Institut National de la Sante` et de la
Recherche Me`dicale. The phagemid vector pBluescript II
KS() was purchased from Stratagene (La Jolla, Calif).
Target cDNAs (1 g/spot) and controls were arrayed in
triplicate on nitrocellulose membranes (0.45-m pore size;
Schleicher & Schuell Protran BA85, Perkin Elmer, Boston,
Mass) with the Bio-Dot SF Microfiltration Apparatus (Bio-
Table I. Summary of in vitro findings on shear stress regulation of endothelial genes grouped by similar function
Gene Biologic activity/function of gene product Shear regulation
I. Vasodilatation, inhibition of SMC proliferation
NOS3 Vasodilatation Direct9,13
Inhibition of: SMC proliferation, platelet aggregation/adhesion, monocyte
adhesion
TGFB1 Inhibition (stimulation) of SMC proliferation Direct11
Regulator of differentiation and extracellular matrix production
II. Vasoconstriction, stimulation of SMC proliferation/migration
Endothelin-1 Vasoconstriction Inverse10,13 (initial increase)
SMC proliferation
Upregulation of collagen synthesis
PDGF B Vasoconstriction Inverse12 (conflicting)
SMC proliferation/migration/chemotaxis
PDGF A Vasoconstriction None12 (conflicting)
SMC proliferation/migration/chemotaxis
FGF2 SMC/EC proliferation Direct12 (conflicting)
Signaling between SMC
Angiogenesis
ACE Vasoconstriction Inverse14 (conflicting)
SMC proliferation (through angiotensin-I to angiotensin-II)
III. Stimulation of EC proliferation/migration
VEGF Vasodilatation (via nitric oxide) Inverse15
EC proliferation
Angiogenesis
Vascular permeability
SMC, Smooth muscle cell.
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Rad Laboratories, Hercules, Calif), according to the in-
structions of the manufacturer.
Individual poly(A) RNA samples were used as tem-
plate (1.0 to 2.5 g) in a reverse transcription reaction
containing 0.5g/g RNA oligo(dT)15 primer (Promega,
Madison, Wis), 1 Moloney murine leukemia virus reac-
tion buffer (Promega), 1 mmol/L dATP/dGTP/dTTP
mix (MBI Fermentas), 0.8 U/L ribonuclease inhibitor
(Sigma, St Louis, Mo), 8 U/L Moloney murine leukemia
virus reverse transcriptase (Promega), nuclease-free water
(Ambion Corp), and 100 Ci 32P-dCTP (110 TBq/
mmol). Sephadex G-50 syringe columns (Sigma) were used
to separate unincorporated nucleotides from the labeled
cDNA probe. DNA-spotted nitrocellulose membranes
were prewet in 6 sodium chloride–sodium phosphate
(SSE)–ethylenediamine tetraacetic acid buffer (SSPE), pre-
hybridized at 42° C for 2 hours in 50% formamide, 6
SSPE, 5Denhardt’s reagent, 0.5% sodium dodecyl sulfate
(SDS), and 200 g/mL denatured herring sperm DNA,
and hybridized with the denatured probe at 42° C over-
night. Membranes were washed with 5 SSPE/0.1% SDS
at room temperature, 1 SSPE/0.5% SDS at 37° C, 0.1
SSPE/1.0% SDS at 65° C, rinsed with 6 SSPE, and
imaged on a Betascope 603 Blot Analyzer (Betagen Corp,
Waltham, Mass) for 24 hours.
Total raw counts were calculated (three observations
per gene, on the basis of a single pooled RNA sample at
each shear stress level) and corrected for mean membrane
background. Individual gene expression levels were nor-
malized to mean background corrected GAPD levels for a
given blot. The END1/NOS3 ratio was calculated by
dividing background corrected counts for one gene by the
other (three observations per shear level). A single factor
analysis of variance was performed for repeated measure-
ments over the six WSS levels for each gene. Differences in
expression were assessed with the Student-Newman-Keuls
method for a P value of less than .05.
RESULTS
Individual gene expression changes over the six WSS
groups are shown in Figs 2 and 3, where statistical differ-
ences are indicated relative to baseline gene expression (15
dynes/cm2) in preconditioned cells only. The mean expres-
sion levels 	 standard deviation are also presented in tabu-
lar form (Table II, online only). Calculated fold changes in
gene expression reported in the text are also listed in Table
III (online only).
Effect of preconditioning. The effects of precondi-
tioning on baseline gene expression are shown by compar-
ison of mRNA levels for cells maintained at 15 dynes/cm2
(  0) with those of cells maintained in static culture
(Table III, online only), where differences were seen in six
genes. Preconditioning significantly (P 
 .05) increased
the fold expression of NOS3 (4.1 	 1.4), FGF2 (3.90 	
1.16), VEGF (3.39 	 1.04), and IGF1 (2.8 	 0.7) but
decreased END1 (0.47	 0.05) and PDGFB (0.70	 0.04)
expression levels when compared with the no-flow con-
trols. The importance of these effects is further shown by
comparison of gene expression levels for the static culture
(traditional zero) case with the preconditioned 0 dynes/
cm2 (  15) shear case (Table III, online only). Re-
moval of flow for 6 hours after preconditioning did not
Fig 1. Schematic shows shear stress protocol applied to HUVEC monolayers. On reaching confluency in static
culture, cells were preconditioned at normalized arterial WSS of 15 dynes/cm2 for 24 hours to reset baseline gene
expression. They then were exposed to various step changes in WSS for 6 hours.
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result in a reversion of gene expression to no-flow levels.
Rather, a sustained increase (P 
 .05) was seen in the
expression of NOS3 (3.3 	 0.8), FGF2 (4.26 	 1.19),
VEGF (5.7 	 1.7), and IGF1 (3.1 	 0.8) levels and a
decrease was seen in END1 (0.40 	 0.03) and PDGFB
(0.65 	 0.07) levels.
Multigene expression analysis. Most of the genes
investigated (END1, NOS3, PDGFA, PDGFB, FGF1,
TGFB1, IGF1, and EGF) showed only minor changes in
expression from baseline levels in cells exposed to either no
change (  0 dynes/cm2) in WSS or step decreases ( 
10, 12.5, or 15 dynes/cm2) in WSS (Figs 2 and 3;
Table II, online only). PDGFB did not show any differ-
ences, and the other genes only differed significantly at the
2.5-dynes/cm2 (  12.5) level within this range (P 

.05). Significant differences in gene expression from base-
Fig 2. Mean	 standard deviation expression levels for endothelial genes (n 3 per gene per shear level). A, END1;
B, NOS3; C, PDGFA; D, PDGFB; E, FGF1; and F, FGF2. *P
 .05 from baseline (15 dynes/cm2) in preconditioned
cells. Expression levels in static cultured cells are shown for comparison only.
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line were more often observed in cells exposed to a step
increase in WSS to 25 dynes/cm2 ( 10) or to reversal
of WSS (2.5 dynes/cm2) than for other changes in WSS.
A  of 10 resulted in significantly (P 
 .05) elevated
END1 (2.8 	 0.3), PDGFA (1.5 	 0.4), PDGFB (2.3 	
0.4), TGFB1 (1.5 	 0.2), and ACE (1.38 	 0.18) levels
but depleted NOS3 (0.38 	 0.09), FGF2 (0.60 	 0.07),
TGFA (0.63 	 0.17), VEGF (0.7 	 0.2), and IGF1
(0.63 	 0.09) levels relative to baseline (Table III, online
only). WSS reversal (2.5 dynes/cm2) resulted in in-
creased (P
 .05) END1 (2.4	 0.2) and PDGFB (1.53	
0.10) levels but decreased NOS3 (0.27 	 0.08), FGF1
(0.64	 0.18), FGF2 (0.44	 0.08), TGFA (0.56	 0.12),
VEGF (0.46 	 0.13), IGF1 (0.47 	 0.13), and EGF
(0.4 	 0.2) levels relative to baseline (Table III, online
only).
Fig 3. Mean 	 standard deviation expression levels for endothelial genes (n  3 per gene per shear level). A, TGFA;
B, TGFB1; C, VEGF; D, IGF1; E, EGF; and F, ACE. *P
 .05 from baseline (15 dynes/cm2) in preconditioned cells.
Expression levels in static cultured cells are shown for comparison only.
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END1/NOS3 expression ratio. END1 and nitric
oxide have opposing effects on the vessel wall and appear to
be oppositely regulated by shear stress9,10,13 in a manner
consistent with finding IH at regions of low WSS (Table I).
The balance between these two factors is believed to be
important in vascular physiology and pathology.1 Hence,
the expression ratio END1/NOS3, measured within the
same biologic sample, may provide valuable insight into
interaction between these factors. As shown in Fig 4,
preconditioning significantly reduced the END1/NOS3
ratio relative to that of cells in static culture (0.11	 0.03).
Furthermore, the END1/NOS3 ratio during the 6-hour
period after preconditioning was maintained at baseline
levels in all groups subjected to either a step decrease or no
change of WSS (  15 to 0 dynes/cm2), but in cells
subjected to a step increase of WSS (10) or reversal of
WSS (2.5 dynes/cm2), END1/NOS3 was restored to
near no-flow levels.
Effect of shear stress directionality. Comparison of
normalized gene expression levels for the 2.5 dynes/cm2
(antegrade) with the 2.5 dynes/cm2 (retrograde) shear
cases (equal in magnitude but opposite in direction to
established flow) revealed differences in five of 12 genes
(Table III, online only). Retrograde shear resulted in sig-
nificantly (P 
 .05) elevated END1 (4.1 	 0.5), PDGFA
(1.5	 0.2), PDGFB (2.3	 0.3), and TGFB1 (1.5	 0.2)
levels but depressed NOS3 (0.60 	 0.17) levels when
compared with the antegrade case. Furthermore, the
END1/NOS3 ratio (Fig 4) was 6.7 	 1.6 fold higher in
the retrograde case.
Comparison of normalized gene expression levels at 15
dynes/cm2 (baseline) with the 2.5 dynes/cm2 (retro-
grade) shear case revealed differences in 10 of 12 genes
(Table III, online only). Retrograde shear resulted in sig-
nificantly (P 
 .05) increased END1 (2.4 	 0.2) and
PDGFB (1.53 	 0.10) levels and decreasing NOS3
(0.27	 0.08), FGF1 (0.64	 0.18), FGF2 (0.44	 0.08),
TGFA (0.56 	 0.12), TGFB1 (0.85 	 0.09), VEGF
(0.46 	 0.13), IGF1 (0.47 	 0.13), and ACE (0.71 	
0.15) levels relative to baseline. The END1/NOS3 ratio
was 9.0	 1.9 fold higher for the retrograde shear case (Fig
4).
DISCUSSION
Effect of preconditioning. Exposure of ECs to arte-
rial levels of flow (shear stress) results in changes in mor-
phology1,29 and cellular architecture,30,31 which are con-
sistent with observations in native arteries and appear to be
crucial for adhesion under flow. Ott and Ballermann32
showed that EC adhesion and retention in seeded vascular
grafts were markedly enhanced with preconditioning of the
cells to shear stress. Although several papers have pointed
out limitations in the use of a static culture control,4,23 few
in vitro studies on gene expression in response to shear
stress have adopted a flow preconditioning step.33
Our results support the implementation of a precondi-
tioning phase for WSS studies in vitro. Preconditioning
HUVEC monolayers at arterial levels of shear stress for 24
hours resulted in changes in cell shape and alignment
consistent with previous observations. Comparison of gene
expression levels between a physiologic baseline (precondi-
tioned cells) and the traditional static culture baseline re-
vealed significant differences in six of the 12 genes studied
(END1, NOS3, PDGFB, FGF2, VEGF, and IGF1) and in
the END1/NOS3 ratio (Table III, online only; Fig 4).
Furthermore, these differences were maintained for 6 hours
on removal of flow from preconditioned cells (Table III,
online only), showing a fundamental difference between
our zero-shear level and the traditional static culture zero.
Our results indicate that studies with static culture as a
baseline may tend to overestimate or underestimate the
effects of shear stress on certain genes. For example, in
preconditioned cells, we found END1 mRNA expression
to be less (0.47	 0.05) and NOS3 mRNA expression to be
Fig 4. Mean 	 standard deviation END1/NOS3 mRNA expression ratio (n  3 per shear level). *P 
 .05 from
baseline (15 dynes/cm2) in preconditioned cells. END1/NOS3 expression ratio in static cultured cells is shown for
comparison only.
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 1 Passerini, Milsted, and Rittgers 187
greater (4.1 	 1.4) than that in static culture (Table III,
online only), resulting in an END1/NOS3 ratio that was
dramatically reduced (0.11	 0.03) in preconditioned cells.
This observation is consistent with the inhibition of EC
growth by laminar shear stress previously reported.3 Al-
though previous studies have clearly established a dynamic
response of ECs to mechanical forces (ie, direct or inverse
relationship), the magnitude of these responses (relative to
a static baseline) may in fact be more reflective of adaptive
changes as the cells reacclimate to more physiologic WSS
levels. Similarly, apparent transients in mRNA expression2,4
may simply be reflective of this adaptation. These effects
may mask subtle long-term changes that may be of clinical
significance in a chronic process such as IH.
Multigene expression analysis. The six WSS groups
studied (25, 15, 5, 2.5, 0, and 2.5 dynes/cm2) are
representative of those observed in normal vascular physi-
ology (including under arterial, venous, and low flow con-
ditions) and in the pathology of IH (at near zero, zero, and
low magnitude retrograde flow).25 Our results indicate that
the direction of an applied change in WSS from normal
physiologic levels may be of greater interest than absolute
WSS levels. Analysis of gene expression over six WSS levels
revealed few differences from baseline in cases where cells
were exposed to either no change in WSS (  0 dynes/
cm2) or to step decreases in WSS (10,12.5, or15
dynes/cm2) for 6 hours (Figs 2 & 3; Table II, online only).
Most of the genes studied either showed no differences or
differed from baseline only at the 2.5 dynes/cm2 shear level
(12.5). Analysis at this shear level was complicated by
the choice of GAPD as a control, which led to expression
levels reading consistently low (data not shown). There is
no justification to believe that this level should differ signif-
icantly from both the neighboring 5 (10) and 0 (
15) dynes/cm2 levels (which did not differ from each
other). Furthermore, no differences were seen in the
END1/NOS3 expression ratio over the shear range of 
0 to   15 dynes/cm2 (Fig 4), which, by virtue of its
independent means of normalization, lends support to the
validity of these observations for the individual genes.
The range in WSS considered in our study (0 to 15
dynes/cm2) closely corresponds to that considered by most
previous in vitro studies (with the exception of precondi-
tioning applied), which showed dramatic effects of shear
stress on gene expression.9-15 Thus, a relative lack of differ-
ences over this shear range further underscores the impor-
tance of the preconditioning step in this study and shows
the importance of the proper choice of baseline and zero-
shear levels in the experimental design. However, a com-
parison made in our study that more closely matches those
made in previous studies is that for cells maintained in static
culture versus those exposed to preconditioning (15
dynes/cm2; Table III, online only), which revealed a de-
crease in END1 and PDGFB and an increase in NOS3 and
FGF2, results that are consistent with previous findings
(Table I).
Differences in gene expression from baseline were more
often observed in cells exposed to a step increase in WSS
(  10) or low magnitude reversal of WSS (2.5
dynes/cm2). In fact, results for these two WSS levels were
similar for a particular gene or ratio (Figs 2 and 3). One
might expect gene expression at the 25 dynes/cm2 shear
level (  10; on the high end of normal but well below
levels that would be damaging to the cells) to deviate from
baseline (arterial) levels less than that for a low magnitude
reversing WSS. The 25 dynes/cm2 case was unusual in that
this was the only case where the cells were exposed to a step
increase in WSS relative to baseline (by a factor of 2/3; Fig
1). This essentially represents a step increase from baseline
conditions whose magnitude is similar to the step increases
from static levels described in previous studies. Similarly,
the 2.5 dynes/cm2 shear case was the only case where
cells were exposed to flow (WSS) in the direction opposite
to that established by the preconditioning phase. The sim-
ilarity in outcomes may reflect common adaptive responses
taking place under these two conditions. It is also notewor-
thy that the expression of  actin (included as one of our
internal controls) was elevated in these two cases relative to
baseline (2.13	 0.16 at 25 dynes/cm2 and 1.49	 0.10 at
2.5 dynes/cm2, respectively), which may be reflective of
associated adaptive changes taking place in cytoskeletal
architecture.
Effects of directionality-retrograde shear. The im-
portance of the flow directionality effect is supported by
comparison of the low magnitude retrograde shear case
(2.5 dynes/cm2) with the low magnitude antegrade
shear case (2.5 dynes/cm2), where significant differences
were seen in the expression of five of the 12 genes (includ-
ing an increase in END1 and PDGFB mRNA expression
and a decrease in NOS3 mRNA expression; Table III,
online only) and in the END1/NOS3 ratio (Fig 4). Fur-
thermore, comparison of gene expression for retrograde
shear with baseline levels (15 dynes/cm2) revealed dra-
matic differences, which were observed in 10 of the 12
genes (including increased END1 and PDGFB mRNA
levels and decreased NOS3 and TGFB1 mRNA levels;
Table III, online only) and in the END1/NOS3 ratio (Fig
4). Additional differences that were observed in compari-
son of the baseline with the retrograde shear case may
represent additional effects of shear magnitude in addition
to directionality alone. These observations are in agreement
with the functional dependence of gene expression on WSS
previously reported (Table I)9-15 and are consistent with a
cellular mechanism involving IH progression at regions of
low magnitude reversing shear stress as seen in vivo25 on
the basis of the effects of these factors on vascular smooth
muscle cells.
The arterial bypass graft anastomosis creates a dynamic
environment, with complex oscillatory flow patterns and a
shifting stagnation point. Although there is an important
distinction between oscillatory flow and the steady retro-
grade flow applied in our model, it should be noted that
time-averaged flow is reversed in the mean at several anas-
tomotic sites (ie, heel, toe, and artery floor). Our results
indicate that flow (WSS) directionality may play an impor-
tant role in the pathology of IH, leading to graft failure at a
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cellular level. This point is supported by in vitro studies that
have used an oscillatory (ie, flow reversing) shear stress,
such as that of Ziegler et al,13 which showed dramatic
differences in END1 and NOS3 expression when compar-
ing a nonreversing pulsatile shear stress with a purely oscil-
latory one. Furthermore, this was suggested by the in vivo
results of Keynton et al25 in which IH correlated best with
an oscillatory shear index. Thus, retrograde shear stress may
present a particularly challenging environment to ECs,
requiring a more dramatic adaptive response than other low
but antegrade stresses. This is consistent with the observa-
tion that a spectrum of morphologic and cytoskeletal
changes seem to nonuniformly adapt the EC to flow in a
given direction.1,29-31 Although we would expect that ECs
should readapt to a new flow direction over time and that
this should be reflected in gene expression, complete adap-
tation may not be possible within the dynamic environment
of the anastomosis.
Several comments are appropriate regarding the con-
duct of this study. First, we chose to primarily focus on
measuring the transcriptional levels of numerous genes
over a range of relevant shear stresses (on the basis of results
of a detailed in vivo study in our laboratory25) rather than
obtaining a wealth of time-dependent data. Because IH is a
chronic process leading to graft failure (beyond 30 days), it
is likely that gene expression over an extended period of
time contributes to this process. Being practically limited as
to the duration of our experiments by the in vitro model,
we chose to measure gene expression at 6 hours after shear
stress changes from an established arterial baseline. This
choice was based on indications that gene expression ap-
pears to reach steady state values within this time frame.2,4
Differences observed in the   10 and the retrograde
shear cases at 6 hours may serve as motivation to track
changes further out in time in future experiments.
Second, our focus has been on the expression of mul-
tiple growth factors at the level of transcription. Although
transcriptional changes do not necessarily reflect changes at
the level of protein, they often do. Several of the genes
evaluated in our study (including END1, NOS3, and
TGFB1) have been shown to be consistently regulated at
the protein level for similar shear stress levels (Table I).
With results from this study, at this time, we are not able to
determine the relative importance of transcriptional versus
post-transcriptional regulatory processes for the genes in-
volved. Future studies will evaluate the contributions of
mRNA and expressed protein levels that contribute to IH.
Third, we have chosen to investigate the role of gene
expression in the mechanically responsive endothelium,
given the complex hemodynamic environment to which
the ECs are exposed in the arterial bypass graft anastomosis.
However, IH is a complex process in which other cell types
participate as well. For example, oscillatory flow patterns at
the distal end-to-side anastomosis have the tendency to
elevate the EC overlapping processes and allow platelets,
leukocytes, and blood-borne elements to enter the subin-
tima, also without endothelial injury or disruption. Ulti-
mately, the products of altered gene expression in ECs and
other sources bring about the process of IH, through the
effects on the underlying myoblasts, including cell prolifer-
ation, migration, differentiation, and matrix production.
These complex interactions are best sorted out in an in vivo
model and are the subject of future work.
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Gene
15 dynes/cm2
(  0)
versus
static culture
0 dynes/cm2
(  15)
versus
static culture
25 dynes/cm2
(  10) versus
15 dynes/cm2
(baseline)
–2.5 dynes/cm2
(retrograde)
versus 2.5 dynes/
cm2 (antegrade)
–2.5 dynes/cm2
(retrograde)
versus 15 dynes/
cm2 (baseline)
Endothelin-1 0.47  0.05* 0.40  0.03* 2.8  0.3* 4.1  0.5* 2.4  0.2*
NOS3 4.1  1.4* 3.3  0.8* 0.38  0.09* 0.60  0.17* 0.27  0.08*
PDGFA 1.7  1.0 1.2  0.7 1.5  0.4* 1.5  0.2* 0.9  0.2
PDGFB 0.70  0.04* 0.65  0.07* 2.3  0.4* 2.3  0.3* 1.53  0.10*
FGF1 1.7  0.9 1.99  1.15 1.01  0.11 1.0  0.4 0.64  0.18*
FGF2 3.90  1.16* 4.26  1.19* 0.60  0.07* 0.9  0.3 0.44  0.08*
TGFA 1.5  0.9 1.94  1.10 0.63  0.17* 1.08  0.17 0.56  0.12*
TGFB1 1.0  0.5 0.9  0.4 1.5  0.2* 1.5  0.2* 0.85  0.09*
VEGF 3.39  1.04* 5.7  1.7* 0.7  0.2* 0.8  0.2 0.46  0.13*
IGF1 2.8  0.7* 3.1  0.8* 0.63  0.09* 1.0  0.3 0.47  0.13*
EGF 1.4  1.2 1.39  1.14 1.1  0.4 0.7  0.3 0.4  0.2
ACE 1.0  0.4 0.9  0.4 1.38  0.18* 1.3  0.2 0.71  0.15*
*Indicates P  .05 difference in mean expression levels (n  3).
Gene
Static
culture
Preconditioned Cells
25 dynes/cm2
(  10)
15 dynes/cm2
(  0)
5 dynes/cm2
(  10)
2.5 dynes/cm2
(  12.5)
0 dynes/cm2
(  15)
–2.5 dynes/cm2
(reversal)
Endothelin-1 0.212  0.007 0.276  0.004* 0.099  0.009 0.084  0.008 0.059  0.007* 0.085  0.005 0.238  0.010*
NOS3 0.022  0.005 0.033  0.001* 0.09  0.02 0.074  0.009 0.039  0.008* 0.071  0.004 0.023  0.004*
PDGFA 0.031  0.017 0.078  0.002* 0.050  0.013 0.044  0.001 0.029  0.005* 0.037  0.005 0.043  0.001
PDGFB 0.098  0.006 0.16  0.03* 0.069  0.001 0.067  0.002 0.046  0.006 0.064  0.005 0.105  0.007*
FGF1 0.018  0.009 0.031  0.003 0.030  0.002 0.035  0.003 0.019  0.004* 0.035  0.008 0.019  0.005*
FGF2 0.015  0.004 0.036  0.002* 0.060  0.007 0.048  0.007* 0.028  0.008* 0.066  0.003 0.026  0.004*
TGFA 0.032  0.018 0.031  0.006* 0.049  0.009 0.035  0.004* 0.025  0.003* 0.061  0.006* 0.027  0.003*
TGFB1 0.08  0.04 0.127  0.014* 0.086  0.007 0.072  0.016 0.050  0.007* 0.079  0.007 0.073  0.005
VEGF 0.018  0.006 0.046  0.014* 0.062  0.003 0.073  0.013 0.037  0.004* 0.106  0.001* 0.029  0.008*
IGF1 0.023  0.005 0.040  0.004* 0.064  0.007 0.058  0.009 0.030  0.004* 0.071  0.006 0.030  0.007*
EGF 0.03  0.02 0.038  0.003 0.036  0.011 0.041  0.003 0.021  0.001* 0.036  0.002 0.016  0.007*
ACE 0.039  0.017 0.053  0.004* 0.038  0.004 0.066  0.005* 0.021  0.001* 0.035  0.009 0.027  0.005
*Indicates P  .05 from baseline (15 dynes/cm2) in preconditioned cells (n  3). Static culture values are given for comparison only.
Table III, online only. Fold changes in gene expression  standard deviation
Table II, online only. Mean expression levels  standard deviation for EC genes over varying WSS
